Grant ID

17T-004

Illness

Schizophrenia

Primary Drug/Intervention

Withania somnifera

Primary Dosage

1000 mg/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Dr. Steve Marder, Dr. Bob Buchanan

Sample Size

66

Duration of Study Period for Each Subject

12 weeks

Outcome Measurements

Positive and Negative Syndrome Scale, Clinical Global Impression Scale, Perceived Stress Scale

Results

N/A

Publication

N/A

Link

N/A

PI Name

Dr. Steve Marder, Dr. Bob Buchanan

Degree

N/A

Center

N/A

Institution

University of California Los Angeles, University of Maryland Baltimore

Address

City or Town

N/A

State or Province

California, Maryland

Zip or Postal Code

N/A

Country

USA

Email Address

marder@ucla.edu, rwbochanan@mprc.umaryland.edu